J&J Beats Estimates, Raises Guidance, Yet Stock Swings Sharply on Charges
Johnson & Johnson topped earnings estimates and raised guidance, but shares showed sharp volatility, a divergence traders link to one-time charges rather than weak pharma fundamentals, even as the stock traded higher intraday on Wednesday.